Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikel Gurrea-Rubio

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Medicine|October 24, 2022
The dual role of CD6 as a therapeutic target in cancer and autoimmune diseaseMikel Gurrea-Rubio, David A Fox
Cells|February 25, 2025
CD6 in Human DiseaseMikel Gurrea-Rubio, David A Fox, Javier S Castresana
Frontiers in Immunology|January 22, 2025
Ligands of CD6: roles in the pathogenesis and treatment of cancerMikel Gurrea-Rubio, Feng Lin, Max S Wicha, et al.
International Journal of Molecular Sciences|March 13, 2024
Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial PathwaysMikel Gurrea-Rubio, Qin Wang, Elizabeth A Mills, et al.
Frontiers in Immunology|March 14, 2022
Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma FibrosisPamela J Palisoc, Leah Vaikutis, Mikel Gurrea-Rubio, et al.
Arthritis Research & Therapy|January 7, 2021
Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosisDavid A Fox, Steven K Lundy, Michael L Whitfield, et al.
Arthritis Research & Therapy|March 5, 2021
Correction to: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosisDavid A Fox, Steven K Lundy, Michael L Whitfield, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2024
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
Research Square|October 27, 2023
Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer CellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
JCI Insight|January 26, 2021
CD6 is a target for cancer immunotherapyJeffrey H Ruth, Mikel Gurrea-Rubio, Kalana S Athukorala, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|October 24, 2022
The dual role of CD6 as a therapeutic target in cancer and autoimmune diseaseMikel Gurrea-Rubio, David A Fox
Cells|February 25, 2025
CD6 in Human DiseaseMikel Gurrea-Rubio, David A Fox, Javier S Castresana
Frontiers in Immunology|January 22, 2025
Ligands of CD6: roles in the pathogenesis and treatment of cancerMikel Gurrea-Rubio, Feng Lin, Max S Wicha, et al.
International Journal of Molecular Sciences|March 13, 2024
Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial PathwaysMikel Gurrea-Rubio, Qin Wang, Elizabeth A Mills, et al.
Frontiers in Immunology|March 14, 2022
Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma FibrosisPamela J Palisoc, Leah Vaikutis, Mikel Gurrea-Rubio, et al.
Arthritis Research & Therapy|January 7, 2021
Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosisDavid A Fox, Steven K Lundy, Michael L Whitfield, et al.
Arthritis Research & Therapy|March 5, 2021
Correction to: Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosisDavid A Fox, Steven K Lundy, Michael L Whitfield, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2024
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
Research Square|October 27, 2023
Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer CellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
JCI Insight|January 26, 2021
CD6 is a target for cancer immunotherapyJeffrey H Ruth, Mikel Gurrea-Rubio, Kalana S Athukorala, et al.
Pageof 2